March 2017: The Antibody Update

This month the Antibody Update showcases caffeine as a potential anti-inflammatory agent, how mTOR is related to granuloma formation, and a retinal transplant using induced pluripotent stem cells. Learn more here!

December 2016: The Antibody Update

ProSci's last Antibody Update of 2016 includes the super effective Ebola vaccine developed by Merck, using the common diabetes drug metformin and the antihypertensive syrosingopine to combat cancer, and a link to a highlight review of the immune checkpoint TIGIT. Check it out!

November 2016: The Antibody Update

This months Antibody Update features the first use of CRISPR-Cas9 modified cells being used as therapeutics, the launch of the first vaccine against malaria, and the 21st Century Cures act, which may vastly increase funding of public health agencies for the next decade. Learn more here.

October 2016: The Antibody Update

The October 2016 Antibody Update includes news on a successful combination immunotherapy for cancer, the story of the Yoshinori Ohsumi's Nobel Prize in Medicine, the release of bacterially infected mosquitoes in Brazil to combat the spread of Zika virus, and a reminder to come looking for ProSci at SfN 2016. Get a look at the October's big news round-up here!

September 2016: The Antibody Update

ProSci's top news picks for September 2016 include a paper on a novel monoclonal antibody against parenchymal amyloid-beta for the treatment of Alzheimer's Dementia, a scientist using CRISPR for gene editing of embryos, and an update on the discussion of antibody validation. Also a reminder that SfN 2016 is right around the corner, and we'll hope to see you there!

August 2016: The Antibody Update

ProSci's top news picks for August 2016 include a study on T-cell activity inside tumor tissue, the potential effects of Zika virus in adults, and mRNA therapeutics. We will be attending SfN 2016 in November as well, so stay tuned!

Curing Cancer

ProSci would like to update you on how immunotherapy is being leveraged to battle cancer. Immunotherapy is the heart of multiple, promising cancer treatments in 2016. These treatments aim to harnesses the power of our highly sophisticated immune systems through immune checkpoint inhibitors, genetic modification of T cells, and manipulation of cytokine concentrations.

January 2016: The Antibody Update

The January 2016 Antibody Update covers a study on the monoclonal antibody Natalizumab's unfortunate side effects, cross reactivity of anti-Ebola virus antibodies, and the controversial Hero's of CRISPR paper, excluding Jennifer Doudna's work.

December 2015: The Antibody Update

This month's Antibody Update includes the highlights of the Antibody Engineering and Therapeutics conference, Jimmy Carter's cancer remission, and another cancer antibody designed to target CD-47.